Impact of Religion, Ethics, And Regulation On Stem Cells Research (Stem Cells Series)

The literature review shows that the R&D pipeline starts with a very large number of patents and publications for both adult and embryonic stem cells, indicative of substantial discovery research being conducted in the field. Data on preclinical analyses are not available, however, we do know that the first discoveries are generally followed by a dramatically reduced number of clinical trials, then even fewer products and applications for stem cells. Stem cell research has attracted much attention from all over the world for its immense potential in regenerative medicine and tissue replacement after injury or disease. Numerous groundbreaking discoveries have been made through research conducted all over the world. I hypothesize that throughout the R&D pipeline required to move stem cells into actual products and applications, several variables affect progress from lab to market. This book analyzes all parties involved in clinical trials related to human embryonic research and attempts to determine if an application or product did not go forward due to ethical, regulatory, or religious reasons.. Stem cells are those groups of cells which can generate specialized cells and organs that perform specific functions. In